S. Phan

3.6k citations
42 papers · 2.6k · 3 hit papers · h-index 15

Impact in

  • Oncology top 2%
    • Cancer Treatment and Pharmacology
    • Lung Cancer Research Studies
    • HER2/EGFR in Cancer Research
  • Genetics top 2%
    • Glioma Diagnosis and Treatment

Papers in

    • Brain Metastases and Treatment 12
    • Lung Cancer Treatments and Mutations 9
    • Advanced Breast Cancer Therapies 7
    • Cancer Treatment and Pharmacology 14
    • Lung Cancer Research Studies 7
    • Cancer Immunotherapy and Biomarkers 6

S. Phan

42 papers receiving 2.5k citations

S. Phan's Hit Papers

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer 2013 · 379 citations
3790+7+15Years since publication250500750

Peers

S. Phan
Comparison fields: 5 of 90
  • Oncology 1.3k
  • Genetics 420
  • Pulmonary and Respiratory Medicine 1.2k
  • Cancer Research 397
  • Hepatology 138
Replace D. J. Richel with:
D. J. Richel Netherlands
Aafke H. Honkoop Netherlands
Tinya J. Abrams United States
Leslie B. Lee United States
Cristian Massacesi Italy
Dana T. Aftab United States
Holger Thurm United States
Annetta Krebs United States
Adrian G. Sacher Canada
Radek Lakomý Czechia
S. Phan relative to D. J. Richel Netherlands D. J. Richel's profile →
Citations per field
00.5×1.5×1.9×
D. J. Richel · 1×
Citations per year

Countries citing papers authored by S. Phan

Since Specialization
Citations

This map shows the geographic impact of S. Phan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Phan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Phan more than expected).

Fields of papers citing papers by S. Phan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Phan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Phan. The network helps show where S. Phan may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Phan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Phan Line = papers co-authored together S. Phan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Hit paper breakdown →
2011795
2
Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial
Hit paper breakdown →
2003474
3 2003380
4
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2013379
5 201084
6 201075
7 201950
8 201847
9 201941
10 200934
11 200733
12 200933
13 200724
14 200621
15 201820
16 201712
17 20209
18 20189
19 20079
20 20219

About S. Phan

S. Phan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Brain Metastases and Treatment (12 papers), Lung Cancer Treatments and Mutations (9 papers), Advanced Breast Cancer Therapies (7 papers), Lung Cancer Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer therapeutics and mechanisms (5 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.3k citations), Genetics (420 citations), Pulmonary and Respiratory Medicine (1.2k citations), Cancer Research (397 citations) and Hepatology (138 citations). S. Phan has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Edith A. Perez, Véronique Dièras, John A. Glaspy, Adam Brufsky, Igor Bondarenko, Oleg Lipatov, Nicholas J. Robert, Joyce O’Shaughnessy, Stephen Chan and Xian Zhou. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, Journal of Thoracic Oncology and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact